Accelerating Precision Medicine: Potential and Key Barriers Related to Policy & Technology
The fully realized vision of precision medicine includes the capability to rapidly diagnose, sequence and develop a personalized treatment plan based on combined analysis of genotype, phenotype, environmental, clinical and behavioral data. Accelerating precision medicine to achieve this vision will require new capabilities and speed in personal health, clinical and genomic data storage transfer and analysis, as well as in interoperability and security. Further, precision medicine will demand new private sector, legislative and regulatory approaches for review and approval of genomic sequencing technologies and other software and devices needed to advance knowledge of disease factors that demonstrate variability among individuals.
Recognizing the current state of precision medicine, and pressures to accelerate the discovery of technology and policy solutions to meet its potential, Intel embarked on the Accelerating Precision Medicine program at the 2016 Connected Health Conference, with a goal to coalesce expert and public opinions about technology and policy barriers in the field. The program consisted of a main stage panel, “Accelerating Precision Medicine,” and two workshops: “Part I: Defining Policy Changes Needed for Accelerating Precision Medicine” and “Part II: Overcoming Technology Barriers to Precision Medicine”. This publication, developed by HIMSS Analytics and the Personal Connected Health Alliance, is the output from that program.